Bibliography
- Exploiting Chemical Diversity for Drug Discovery. Edited by Bartlett P and Entzeroth M. Royal Society of Chemistry, Cambridge (UK), 2006
- Schneider G, Grabowski K. Properties and Architecture of Drugs and Natural Products Revisited. Curr Chemical Biol 2007;1:115-27
- Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70:461-77
- Rouhi AM. Rediscovering natural products. Chem Eng News 2003;81(41):77-8
- Schreiber SL. Organic chemistry: Molecular diversity by design. Nature 2009;457:153-4
- Le GT, Abbenante G, Becker B, et al. Molecular diversity through sugar scaffolds. Drug Discovery Today 2003;8:701-9
- Lajiness M, Watson I. Dissimilarity-based approaches to compound acquisition. Curr Opin Chem Biol 2008;12:366-71
- Schawrz MK, Sauer WHB. Molecular Shape Diversity of Combinatorial Libraries: A Prerequisite for Broad Bioactivity. J Chem Inf Comput Sci 2003;43:987-1003
- Haggarty SJ. The principle of complementarity: chemical versus biological space. Curr Opin Chem Biol 2005;9:296-303
- Shelat AA, Guy RK. Scaffold composition and biological relevance of screening libraries. Nat Chem Biol 2007;3:442-6
- Kennedy JP, Williams L, Bridges TM, et al. Application of Combinatorial Chemistry Science on Modern Drug Discovery. J Comb Chem 2008;10:345-54
- Spring DR. Diversity-oriented synthesis; a challenge for synthetic chemists. Org Biomol Chem 2003;1:3867-70
- Burke MD, Schreiber SL. A planning strategy for diversity-oriented synthesis. Angew Chem, Int Ed 2004;43:46-58
- Burke MD, Berger EM, Schreiber SL. Generating diverse skeletons of small molecules combinatorially. Science 2003;302:613-8
- Lipinski C, Hopkins A. Navigating chemical space for biology and medicine. Nature 2004;432:855-61
- von Nussbaum F, Brands M, Hinzen B, et al. Antibacterial natural products in medicinal chemistry - Exodus or revival? Angew Chem, Int Ed 2006;45(31):5072-129
- Kaiser M, Wetzel S, Kumar K, Waldmann H. Biology-inspired synthesis of compound libraries. Cell Mol Life Sci 2008: published online 15th January 2006, doi 10.1007/s00018-007-7492-1
- Noren-Muller A, Reis-Correa I, Prinz H, et al. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. Proc Nat Acad Sci USA 2006;103:10606-11
- Desimone RW, Currie KS, Mitchell SA, et al. Privileged Structures: Applications in Drug Discovery. Comb Chem High Throughput Screening 2004;7:473-93
- Koch MA, Schuffenhauer A, Scheck M, et al. Charting biologically relevant chemical space: A structural classification of natural products (SCONP). Proc Nat Acad Sci USA 2005;102:17272-7
- Spandl RJ, Spring DR. Diversity-oriented synthesis; a spectrum of approaches and results. Org Biomol Chem 2008;6:1149-58
- Borman S. Rescuing Combichem. Chem Eng News: Science and Technology. 2004;82(40):32-40
- Morton D, Leach S, Cordier C, et al. Synthesis of natural-product-like molecules with over eighty distinct scaffolds. Angew Chem, Int Ed 2009;48:104-9
- Wyatt EE, Fergus S, Galloway WRJD, et al. Skeletal diversity construction via a branching synthetic strategy. Chem Commun 2006;3296-98
- Wyatt EE, Galloway WRJD, Thomas GL, et al. Identification of an anti–MRSA dihydrofolate reductase inhibitor from a diversity–oriented synthesis. Chem Commun, 2008;4962-64
- Nielsen TE, Schreiber SL. Diversity-oriented synthesis - Towards the optimal screening collection: A synthesis strategy. Angew Chem, Int Ed 2008;47:48-56